See What HealthDay Can Do For You
Contact Us

DOJ Asks Congress to Permanently Classify Fentanyl-Like Drugs

2018 temporary order that tightened controls on fentanyl-like drugs expires in February 2020

opioid crisis

WEDNESDAY, July 3, 2019 (HealthDay News) -- A temporary order classifying fentanyl-like drugs as controlled substances should be enacted into law, the U.S. Department of Justice is telling Congress.

The order -- which was enacted in 2018 on an emergency basis and expires in February 2020 -- tightened controls on fentanyl-like drugs, which had skirted federal law because their chemical makeup is slightly different than the opioid fentanyl, which is about 100 times stronger than morphine, CBS News reported. Fentanyl-like drugs can be even stronger.

"From a policy and regulatory perspective, fentanyl-like substances need to be permanently scheduled as a class," said Katie Crytzer, the acting deputy assistant attorney general in the Office of Legal Policy at the Department of Justice, CBS News reported. The classification is an "urgent and necessary first step," she told reporters Monday.

Of the more than 70,000 drug overdose deaths in the U.S. in 2017, nearly 48,000 were caused by opioids, and about 29,000 by fentanyl or fentanyl-like substances, according to U.S. Centers for Disease Control and Prevention data, said John Martin, assistant administrator of the Drug Enforcement Administration, CBS News reported.

CBS News Article

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.